0001213900-23-015607.txt : 20230301 0001213900-23-015607.hdr.sgml : 20230301 20230228185458 ACCESSION NUMBER: 0001213900-23-015607 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230301 DATE AS OF CHANGE: 20230228 EFFECTIVENESS DATE: 20230301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allarity Therapeutics, Inc. CENTRAL INDEX KEY: 0001860657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-474534 FILM NUMBER: 23688586 BUSINESS ADDRESS: STREET 1: 24 SCHOOL ST., 2ND FLOOR CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 401-426-4664 MAIL ADDRESS: STREET 1: 24 SCHOOL ST., 2ND FLOOR CITY: BOSTON STATE: MA ZIP: 02108 D 1 primary_doc.xml X0708 D LIVE 0001860657 Allarity Therapeutics, Inc. 24 SCHOOL STREET, 2ND FLOOR BOSTON MA MASSACHUSETTS 02108 (401) 426-4664 DELAWARE None None Corporation true 2021 James G. Cullem 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Executive Officer Director Joan Brown 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Executive Officer Gerald McLaughlin 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Director David A. Roth 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Director Thomas Jensen 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Director Biotechnology Decline to Disclose 06b false 2023-02-28 false true true Series C Preferred Stock; common stock issuable upon the conversion of Series CPreferred Stock false 0 1200000 1200000 0 false 1 0 0 0 false Allarity Therapeutics, Inc. /s/ James G. Cullem James G. Cullem CEO and President 2023-02-28